BamSEC and AlphaSense Join Forces
Learn More

Celldex Therapeutics Inc. – Material Contracts

NASDAQ: CLDX    
Share price (7/8/26): $38.96    
Market cap (7/8/26): $3.058 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 2 pages Amendment No. 4 to Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan Dated: April 19, 2026
12/34/56
EX-10.17
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.16
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.15
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.14
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.13
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.12
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.11
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.10
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.9
from 10-K 22 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 10-Q 21 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 3 to Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan Dated: April 10, 2025
12/34/56
EX-10.17
from 10-K 4 pages Fourth Amendment to Lease Agreement
12/34/56
EX-10.12
from 10-K 7 pages Eleventh Amendment to Lease
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 2 to Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan Dated: April 12, 2024
12/34/56
EX-10.1
from 8-K 1 page Amendment to Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan Dated: April 11, 2023
12/34/56
EX-10.2
from 10-Q 6 pages Tenth Amendment to Lease
12/34/56
EX-10.1
from 10-Q 41 pages Fourth Amended and Restated License Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Third Amendment of Lease
12/34/56
EX-10.1
from 8-K 10 pages Confidential Settlement Agreement and Mutual Release
12/34/56